Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Vascular Embolization Plugs and Coils are used for occlusion of blood flow to abnormal area of a tissue by non-surgical methods. GlobalData uses proprietary data and analytics to provide a comprehensive report on the vascular embolization plugs and coils devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the vascular embolization plugs and coils market in New Zealand was Terumo followed by Medtronic, Boston Scientific, Cook Medical, Abbott Laboratories, Penumbra and Balt.

Vascular Embolization Plugs are expandable nitinol mesh vascular occlusion devices used to obstruct the blood flow in the vasculature. Pushable Vascular Embolization Coils are fibered platinum coils that are used for mechanical vessel occlusion in indications such as peripheral aneurysm, peripheral AVMs, type II endoleak and gastrointestinal bleeding. Detachable Vascular Embolization Coils are composed of platinum or platinum tungsten alloy used for the mechanical embolization of the affected vessel.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the vascular embolization plugs and coils devices market within New Zealand was expected to be over $2m in 2022.

For the latest complete market share analysis of vascular embolization plugs and coils device market in New Zealand, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.